Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis?
about
The Use of Thrombopoietin Receptor Agonists for Correction of Thrombocytopenia prior to Elective Procedures in Chronic Liver Diseases: Review of Current EvidenceReview article: thrombocytopenia in chronic liver disease and pharmacologic treatment options.Pathobiology and treatment of hepatitis virus-related thrombocytopenia.Causes of thrombocytopenia in chronic hepatitis C viral infection.Coated transjugular intrahepatic portosystemic shunt does not improve thrombocytopenia in patients with liver cirrhosis.Romiplostim in the management of thrombocytopenia in a patient with autoimmune hepatitis.Peripheral platelet count correlates with liver atrophy and predicts long-term mortality on the liver transplant waiting list.Thrombocytopenia in patients with hepatitis B virus-related chronic hepatitis: evaluation of the immature platelet fraction.The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia.Management of thrombocytopenia in advanced liver diseaseManagement of Thrombocytopenia in Chronic Liver Disease: Focus on Pharmacotherapeutic Strategies.Utility of Doppler ultrasonography for predicting improvement of platelet count after transjugular intrahepatic portosystemic shunt.Thrombocytopenia in chronic liver disease.The Effect of Transjugular Intrahepatic Portosystemic Shunt on Platelet Counts in Patients With Liver Cirrhosis.New insights into the coagulopathy of liver disease and liver transplantationHypersplenism in liver disease and SLE revisited: current evidence supports an active rather than passive process.Abnormal hematological indices in cirrhosis.
P2860
Q28074484-A76AB696-0317-4F5C-BF5C-B399E0F33849Q33370831-8ECB0444-3BFE-4211-9ACE-5F553E71A776Q33394547-AAB4BB0A-D81F-4A72-8CE2-EFBD87A293CEQ33399654-FDB070D9-F8C2-4363-B412-38A3D4226479Q33401230-84A004B7-AF27-406E-9D30-2037704AE144Q33402513-D608685B-E1F5-48B9-B9B1-F45471DBA147Q33405520-F9579F20-03CD-4E41-93E2-BE2B9D9739C5Q33410431-B1C7D208-7772-4C6B-9CA6-F489204AF101Q33414386-90043031-A9B0-42E9-B90B-C0D79FAAB097Q33417667-D9B45081-85F3-48EB-8B50-B4C2F2881249Q33427048-E2DF1BB5-E849-4D9F-84C9-126D27A9259BQ33435715-1D983E2B-68F1-48FA-8D9B-B251E00E1496Q33436905-B6DD9369-B348-4F71-A213-293A8F189FADQ33443052-EB8B34B7-31A9-4FAF-9ABF-2A18CE4A2A29Q33866656-303E7D61-896B-4BDB-AE05-2282E51F20A6Q35920464-81288CBD-60A1-479A-A9E2-BD142A6FF290Q37291711-7E49AE86-2F10-45E2-A583-7D4C8F09329F
P2860
Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis?
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Does transjugular intrahepatic ...... nia associated with cirrhosis?
@ast
Does transjugular intrahepatic ...... nia associated with cirrhosis?
@en
type
label
Does transjugular intrahepatic ...... nia associated with cirrhosis?
@ast
Does transjugular intrahepatic ...... nia associated with cirrhosis?
@en
prefLabel
Does transjugular intrahepatic ...... nia associated with cirrhosis?
@ast
Does transjugular intrahepatic ...... nia associated with cirrhosis?
@en
P2093
P356
P1476
Does transjugular intrahepatic ...... nia associated with cirrhosis?
@en
P2093
P2888
P304
P356
10.1023/A:1026634215918
P577
1998-11-01T00:00:00Z
P6179
1023155975